Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TyVEGHA typhoid conjugate vaccine cluster-randomized trial in Ghana
PACTR202011804563392Phase 4Not yet recruiting
- Sponsor
- International Vaccine Institute
- Start
- Mar 2021
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in typhoid fever (2 arms), sponsored by International Vaccine Institute. Primary endpoint: Incidence of blood culture-confirmed symptomatic typhoid fever in vaccine recipients. Planned start Mar 2021; status: not yet recruiting.
02
Conditions
typhoid fever
Beyond the preview
Go deeper on PACTR202011804563392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202011804563392.